Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 1;64(4):2115-2122.
doi: 10.1093/rheumatology/keae470.

Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies

Affiliations

Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies

XingYao Wang et al. Rheumatology (Oxford). .

Abstract

Objective: This study aims to evaluate the diagnostic accuracy of CA-125 and PET/CT in detecting cancer among adult patients with idiopathic inflammatory myopathy (IIM).

Methods: We conducted a retrospective study of a single-centre cohort of adult IIM patients enrolled from 2003 to 2020. Data on CA-125 and PET/CT tests conducted within five years of IIM symptom onset were extracted from electronic medical records. The outcomes assessed included true-positive, false-positive, true-negative and false-negative results.

Results: Among 1432 patients with IIM, 250 CA-125 tests were conducted on 205 patients within the first five years of symptom onset, yielding a false-positive rate of 3.1% and a false-negative rate of 14.3%. Most false-positives were associated with endometriosis or uterine fibroids, but additional medical procedures were often carried out to investigate the false-positive results. For PET/CT, 149 tests were performed on 139 patients, resulting in a false-positive rate of 5.5% and a false-negative rate of 28.6%. Lymphadenopathy and lung nodules were the predominant causes of false-positives, while melanoma, low-stage breast cancer and prostate cancer were the most frequent cancers missed (false-negatives).

Conclusion: False-positive and false-negative results are prevalent in cancer antigen 125 (CA-125) and PET/CT testing for adult patients with newly diagnosed idiopathic inflammatory myopathy. Understanding the causes of these inaccuracies can aid clinicians in making informed decisions during patient care.

Keywords: cancer; cancer screening; dermatomyositis; immune-mediated necrotizing myopathy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
2 × 2 Tables of true-positive, false-positive, false-negative, and true-negative results for CA-125 and ovarian cancer. A total of 205 patients underwent CA-125 testing; however, five patients were ommitted due to to an inability to verify the outcome
Figure 2.
Figure 2.
2 × 2 Tables of true-positive, false-positive, false-negative, and true-negative results for PET/CT and cancer. A total of 139 patients underwent PET/CT testing; however, two patients were ommitted due to an inability to verify the outcome

References

    1. Oldroyd AGS, Allard AB, Callen JP. et al. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology 2021;60:2615–28. - PMC - PubMed
    1. Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg Ø. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. Semin Arthritis Rheum 2015;45:301–8. - PubMed
    1. Lim CH, Tseng C-W, Lin C-T. et al. The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: a retrospective study. SAGE Open Med 2018;6:2050312118781895. - PMC - PubMed
    1. Selva-O'Callaghan A, Trallero-Araguás E, Ros J. et al. Management of cancer-associated myositis. Curr Treatm Opt Rheumatol 2022;8:91–104. - PMC - PubMed
    1. Hill CL, Zhang Y, Sigurgeirsson B. et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96–100. - PubMed